HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Of 49 countries surveyed in a recent analysis, 15 have historically relied on the the U.S. for most of the funding for their ...

University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure: Their ...

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

There’s also ongoing work on a potential HIV vaccine. To find out more about HIV drugs that are currently available (and those that may become available in the future), talk with a healthcare ...

University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure: Their ...

The study uncovered how HIV “hides,” an understanding that could help future treatments find and eradicate it.

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

New HIV research shows that small changes in the virus affect how quickly or slowly it replicates and how easily it can reawaken in the body. These insights bring researchers closer to finding ways to ...

One of the first nonprofit organizations in New Hampshire to take on the AIDS epidemic says its work isn't done yet.

Exploring caregiver dependence and social determinants of health reveals critical barriers to HIV care for children, ...

The US cuts in research funding are devastating to the fight against HIV/Aids. It’s going to be very hard to recover.